| A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC) (NCT05310981) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-07-06 |
| Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use (NCT05445180) | Douglas Mental Health University Institute | 2022-04-21 |
| SV2A Density Cannabis Use Disorder (NCT05472818) | Yale University | 2022-04-12 |
| The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV (NCT05453513) | University of Miami | 2022-04-01 |
| Breathwork-assisted Treatment for Cannabis Use Disorder (NCT05219825) | Elias Dakwar | 2022-02-06 |
| Vivitrol Treatment for Cannabis Use Disorder (NCT04139668) | Centre for Addiction and Mental Health | 2021-06-09 |
| Investigating Stress-related Mechanisms in the Laboratory and Real World in Individuals With Cannabis Use Disorder (NCT04116619) | Yale University | 2021-02-01 |
| Pilot Testing the Check Up (NCT04624074) | University of Maryland, Baltimore | 2021-01-01 |
| Comparing the Spanish Version of CANreduce With or Without Psychological Support and Treatment as Usual, Reducing Cannabis Use. (NCT04517474) | Parc de Salut Mar | 2020-11-10 |
| Reducing Cannabis Overuse With Prazosin (NCT04721353) | VA Puget Sound Health Care System | 2020-11-09 |
| UH3 Varenicline for Cannabis Use Disorder (NCT03980561) | Medical University of South Carolina | 2020-01-31 |
| Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders (NCT05726617) | Ciusss de L'Est de l'Île de Montréal | 2019-09-24 |
| Lorcaserin for Cannabis Use Disorder (NCT03637842) | New York State Psychiatric Institute | 2019-08-01 |
| Maternal Marijuana Use and Fetal and Infant Outcome (NCT04266314) | Johns Hopkins University | 2019-04-10 |
| Approach Bias Modification for the Treatment of Cannabis Use Disorder (NCT03629990) | Medical University of South Carolina | 2019-01-16 |
| Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD) (NCT03386487) | Yale University | 2019-01-14 |
| The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity (NCT03718520) | University of Colorado, Denver | 2018-11-07 |
| Effects of Cannabis Abstinence on Symptomology and Cognition in Bipolar Disorder (NCT03629106) | Centre for Addiction and Mental Health | 2018-10-01 |
| Substance Misuse To Psychiatric Disorders for Cannabis (NCT03485274) | The University of Hong Kong | 2018-07-25 |
| Affective Management Training for Cannabis Misuse (NCT03432013) | University of California, Los Angeles | 2018-02-15 |
| Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam (NCT03398083) | National Institute on Drug Abuse (NIDA) | 2017-12-04 |
| SV2 PET Imaging With [11C]APP311 (NCT03995121) | Yale University | 2017-12-01 |
| Effects of Cannabis Abstinence on Symptoms and Cognition in Depression (NCT03624933) | Centre for Addiction and Mental Health | 2017-11-06 |
| Gabapentin for Bipolar & Cannabis Use Disorders (NCT03334721) | Medical University of South Carolina | 2017-10-01 |
| Brain Imaging of Cannabinoid Receptors (NCT03204305) | Johns Hopkins University | 2017-09-14 |
| N-Acetylcysteine for Youth Cannabis Use Disorder (NCT03055377) | Medical University of South Carolina | 2017-08-03 |
| A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder (NCT03144232) | Stanford University | 2017-08-01 |
| Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia (NCT03189810) | Centre for Addiction and Mental Health | 2017-06-01 |
| Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC) (NCT03056482) | Dr. Marco L.A. Sivilotti | 2017-05-21 |
| Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients (NCT02913924) | New York State Psychiatric Institute | 2016-12-01 |
| rTMS Treatment for Cannabis Use Disorders in Psychosis (NCT03069612) | Centre for Addiction and Mental Health | 2016-12-01 |
| Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder (NCT02932215) | New York State Psychiatric Institute | 2016-10-01 |
| Computerized Intervention for Distress Intolerance (NCT04173078) | Auburn University | 2016-06-01 |
| N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms (NCT03221231) | Universitair Ziekenhuis Brussel | 2016-05-15 |
| Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder (NCT03102918) | Mclean Hospital | 2016-02-20 |
| Clinical Trial Tobacco Marijuana (NCT02277665) | Dartmouth-Hitchcock Medical Center | 2014-12-18 |
| Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence (NCT02210195) | The Scripps Research Institute | 2014-09-04 |
| Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? (NCT01964404) | Dartmouth-Hitchcock Medical Center | 2014-07-01 |
| Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study (NCT02083874) | The University of New South Wales | 2014-03-01 |
| Cannabidiol: a Novel Intervention for Cannabis Use Problems? (NCT02044809) | University College, London | 2014-03-01 |
| Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders (NCT01875796) | Louisiana State University and A&M College | 2013-06-01 |
| Buspirone, Stress, and Attentional Bias to Marijuana Cues (NCT02132832) | The University of Texas Health Science Center, Houston | 2013-06-01 |
| Adaptive Treatment for Adolescent Cannabis Use Disorders (NCT01656707) | UConn Health | 2011-09-01 |
| Teen Marijuana Check-Up (NCT01109563) | Denise Walker | 2011-03-01 |
| Cannabis and Schizophrenia: Self-Medication and Agonist Treatment (NCT00946348) | Dartmouth-Hitchcock Medical Center | 2009-12-01 |